These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8306478)

  • 1. The effect of oestradiol implants on regional and total bone mass: a three-year longitudinal study.
    Ryde SJ; Bowen-Simpkins K; Bowen-Simpkins P; Evans WD; Morgan WD; Compston JE
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):33-8. PubMed ID: 8306478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites.
    Perry W; Wiseman RA
    BJOG; 2000 Nov; 107(11):1401-6. PubMed ID: 11117769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women.
    Studd JW; Holland EF; Leather AT; Smith RN
    Br J Obstet Gynaecol; 1994 Sep; 101(9):787-91. PubMed ID: 7947528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens.
    Savvas M; Studd JW; Norman S; Leather AT; Garnett TJ; Fogelman I
    Br J Obstet Gynaecol; 1992 Sep; 99(9):757-60. PubMed ID: 1420016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total body calcium in patients with inflammatory bowel disease: a longitudinal study.
    Ryde SJ; Clements D; Evans WD; Motley R; Morgan WD; Evans C; Rhodes J; Compston JE
    Clin Sci (Lond); 1991 Apr; 80(4):319-24. PubMed ID: 1851067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.
    Grey AB; Cundy TF; Reid IR
    Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants.
    Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R
    Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.
    Evans SF; Davie MW
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):79-84. PubMed ID: 8706298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy.
    Wahab M; Ballard P; Purdie DW; Cooper A; Willson JC
    Br J Obstet Gynaecol; 1997 Jun; 104(6):728-31. PubMed ID: 9197878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 25-mg percutaneous estradiol implants on the bone mass of postmenopausal women.
    Holland EF; Leather AT; Studd JW
    Obstet Gynecol; 1994 Jan; 83(1):43-6. PubMed ID: 8272305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.
    Grey A; Cundy T; Evans M; Reid I
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):293-6. PubMed ID: 8729524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants.
    Holland EF; Leather AT; Studd JW
    Br J Obstet Gynaecol; 1995 Mar; 102(3):238-42. PubMed ID: 7794850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration.
    Dick IM; Prince RL; Kelly JJ; Ho KK
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):219-24. PubMed ID: 7554318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of percutaneous oestradiol versus oral oestrogens on bone density.
    Palacios S; Menéndez C; Jurado AR; Vargas JC
    Maturitas; 1994 Dec; 20(2-3):209-13. PubMed ID: 7715474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.
    Lehmke J; Bogner U; Felsenberg D; Peters H; Schleusener H
    Clin Endocrinol (Oxf); 1992 May; 36(5):511-7. PubMed ID: 1617803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
    Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.
    Schneider DL; Barrett-Connor EL; Morton DJ
    JAMA; 1994 Apr; 271(16):1245-9. PubMed ID: 7848399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.